Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06885918 · ClinicalTrials.gov registry record

ALS Research Collaborative

A clinical trial of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by ALS Therapy Development Institute.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT06885918: Recruiting study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by ALS Therapy Development Institute.

NCT06885918 is a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease that is actively recruiting participants, run by ALS Therapy Development Institute. The registered enrollment target is 2,000 participants, above the 878-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06885918, a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, is actively recruiting participants, sponsored by ALS Therapy Development Institute.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.

Primary Outcome

A questionnaire completed by the participant that assesses 12 daily functions of living on a 0 (severe symptoms) to 4 (minimal to no symptoms) integer scale.

Conditions Studied

Amyotrophic Lateral Sclerosis Motor Neuron Disease ALS (Amyotrophic Lateral Sclerosis) Motor Neuron Disease, Amyotrophic Lateral Sclerosis ALS With Frontotemporal Dementia (ALS/FTD)

Study Locations (1)

Massachusetts

  • ALS Therapy Development Institute - Watertown

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2014-09-12
Est. Completion 2035-01-31
ALS Therapy Development Institute

1 total trials

What NCT06885918 shows while recruiting

NCT06885918 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 878-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (128% higher).

The record links to 5 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT06885918 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06885918 about?

NCT06885918 is a clinical study titled "ALS Research Collaborative". The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND...

What is the current status of trial NCT06885918?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2014-09-12. Estimated completion is 2035-01-31.

What conditions does trial NCT06885918 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease, ALS (Amyotrophic Lateral Sclerosis), Motor Neuron Disease, Amyotrophic Lateral Sclerosis, ALS With Frontotemporal Dementia (ALS/FTD).

Who is sponsoring clinical trial NCT06885918?

This trial is sponsored by ALS Therapy Development Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06885918 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06885918's enrollment target sits among peer trials

2,000 7th of 102 higher than 95 of 102 other Amyotrophic Lateral Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06885918

Source: ClinicalTrials.gov NCT06885918, the US trial registry maintained by the National Library of Medicine. NCT06885918 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.